HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

entinostat (MS 275)

structure in first source
Also Known As:
MS 275; MS 27-275; MS-27-275; MS-275; N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide; SNDX-275; Carbamic acid, N-((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)-, 3- pyridinylmethyl ester
Networked: 387 relevant articles (52 outcomes, 100 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Trepel, Jane B: 13 articles (11/2021 - 02/2002)
2. Lee, Min-Jung: 11 articles (11/2021 - 01/2004)
3. Ordentlich, Peter: 11 articles (01/2020 - 11/2009)
4. Connolly, Roisin M: 9 articles (01/2022 - 01/2016)
5. Figg, William D: 9 articles (01/2020 - 05/2004)
6. Pili, Roberto: 9 articles (12/2017 - 05/2005)
7. Gore, Steven D: 8 articles (11/2021 - 10/2005)
8. Piekarz, Richard: 8 articles (11/2021 - 05/2017)
9. Sausville, Edward A: 7 articles (04/2007 - 02/2002)
10. Gameiro, Sofia R: 6 articles (01/2022 - 02/2016)

Related Diseases

1. Neoplasms (Cancer)
2. Breast Neoplasms (Breast Cancer)
3. Lung Neoplasms (Lung Cancer)
4. Neoplasm Metastasis (Metastasis)
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. Histone Deacetylase Inhibitors
2. entinostat (MS 275)
3. Valproic Acid (Depakote)
4. Histone Deacetylases (Histone Deacetylase)
5. exemestane (Aromasin)
6. Vorinostat
7. Aromatase Inhibitors
8. Proteins (Proteins, Gene)
9. Butyric Acid (Butanoic Acid)
10. mocetinostat

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Oral Administration
4. Chemoprevention
5. Radiotherapy